2013
Glioblastoma and Other Malignant Gliomas: A Clinical Review
Omuro A, DeAngelis LM. Glioblastoma and Other Malignant Gliomas: A Clinical Review. JAMA 2013, 310: 1842-1850. PMID: 24193082, DOI: 10.1001/jama.2013.280319.Peer-Reviewed Original ResearchMeSH KeywordsCombined Modality TherapyEnvironmental ExposureGenetic Predisposition to DiseaseGlioblastomaHumansRiskConceptsMalignant gliomasRisk factorsAmerican Heart Association classification systemCommon primary malignant brain tumorPrimary malignant brain tumorGrade III tumorsStandard of careSpecific antitumor therapyMalignant brain tumorsAuthors' own filesFrequent clinical complicationEnvironmental risk factorsCertain genetic syndromesOwn filesTerms glioblastomaThromboembolic eventsCommon complicationNeurologic symptomsOverall prognosisAnnual incidenceDismal prognosisSymptom managementClinical reviewTherapeutic optionsClinical complications
2007
Editorial: what is new in the treatment of gliomas?
Omuro AM, Delattre JY. Editorial: what is new in the treatment of gliomas? Current Opinion In Neurology 2007, 20: 704-707. PMID: 17992093, DOI: 10.1097/wco.0b013e3282f1beef.Peer-Reviewed Original ResearchConceptsTreatment of gliomaTherapeutic decisionsEvidence-based therapeutic decisionsBevacizumab-based combinationsRecurrent malignant gliomaRole of chemotherapyPhase II trialStandard of carePhase III evidenceHigh response ratePhase II resultsSingle positive resultTemozolomide concomitantTemozolomide schedulesII trialSurvival benefitRandomized trialsGrade IIIMalignant gliomasResponse rateGliomasSuch trialsTraditional treatmentTrialsCodeletion status